Open AccessAssessing the Accuracy, Quality, and Readability of Patient Accessible Online Resources Regarding Ocular Gene Therapy and Voretigene Neparvovec
Author(s) -
Swetha Davuluri,
Nicolas A. Yannuzzi,
Amy Kloosterboer,
Ajay E. Kuriyan,
Jayanth Sridhar
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s324231
Subject(s) - readability , medicine , reading (process) , quality score , food and drug administration , family medicine , population , quality (philosophy) , ophthalmology , pharmacology , environmental health , computer science , metric (unit) , philosophy , operations management , epistemology , political science , law , economics , programming language
To evaluate the accuracy, quality, and readability of online information regarding the Food and Drug Administration (FDA) approved ocular gene therapy voretigene neparvovec (Luxturna, Spark Therapeutics, Philadelphia, PA, USA).